Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

8.880 -0.390 (-4.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,919,784
Open 9.240
Bid (Size) 8.900 (1)
Ask (Size) 9.000 (49)
Prev. Close 9.270
Today's Range 8.835 - 9.270
52wk Range 6.850 - 13.55
Shares Outstanding 1,212,301,241
Dividend Yield 5.41%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session: S&P500 movers
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
Viatris Hits Snag In Eye Drug Study—Phase 3 Plans Under Review
Viatris' Phase 3 trial for pimecrolimus 0.3% in blepharitis did not meet its primary goal, prompting the company to reassess its development strategy. 
Via Benzinga

Performance

YTD
-28.5%
-28.5%
1 Month
+0.1%
+0.1%
3 Month
+17.3%
+17.3%
6 Month
-21.6%
-21.6%
1 Year
-25.0%
-25.0%

More News

Read More
Top S&P500 movers in Friday's session
Via Chartmill
Why Viatris (VTRS) Stock Is Falling Today
Via StockStory
What's going on in today's session: S&P500 gap up and gap down stocks
Via Chartmill
Q1 Earnings Highs And Lows: Viatris (NASDAQ:VTRS) Vs The Rest Of The Generic Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
3 S&P 500 Stocks in Hot Water
Via StockStory
Topics Stocks
Viatris Eye Drops Data Shows Promise For Blurred Near Vision
Via Benzinga
3 Unprofitable Stocks with Mounting Challenges
Via StockStory
3 Healthcare Stocks with Questionable Fundamentals
Via StockStory
Topics Stocks
VTRS Q1 Earnings Call: Pipeline Advances, Tariff Risks, and Strategic Cost Review
Via StockStory
Topics Economy World Trade
Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?
Via Benzinga
Viatris Deadline Today: Rosen Law Firm Urges Viatris Inc. (NASDAQ: VTRS) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
From Pomerantz LLP
Via GlobeNewswire
VIATRIS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Viatris Inc. - VTRS
From Kahn Swick & Foti, LLC
Via Business Wire
Deadline Soon: Viatris Inc. (VTRS) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
SHAREHOLDER REMINDER: Berger Montague Reminds Viatris (NASDAQ: VTRS) Investors of the June 3, 2025 Deadline
From Berger Montague
Via GlobeNewswire
VTRS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important June 3 Deadline in Securities Class Action – VTRS
From The Rosen Law Firm PA
Via GlobeNewswire
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - VTRS
From SkyMedia, LLC
Via GlobeNewswire
VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
From Pomerantz LLP
Via GlobeNewswire
VIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - VTRS
From Kahn Swick & Foti, LLC
Via GlobeNewswire
DEADLINE NEXT WEEK: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Contact the Firm Before June 3, 2025
From Berger Montague
Via GlobeNewswire

Frequently Asked Questions

Is Viatris Inc. - Common Stock publicly traded?
Yes, Viatris Inc. - Common Stock is publicly traded.
What exchange does Viatris Inc. - Common Stock trade on?
Viatris Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viatris Inc. - Common Stock?
The ticker symbol for Viatris Inc. - Common Stock is VTRS on the Nasdaq Stock Market
What is the current price of Viatris Inc. - Common Stock?
The current price of Viatris Inc. - Common Stock is 8.880
When was Viatris Inc. - Common Stock last traded?
The last trade of Viatris Inc. - Common Stock was at 07/18/25 04:00 PM ET
What is the market capitalization of Viatris Inc. - Common Stock?
The market capitalization of Viatris Inc. - Common Stock is 10.77B
How many shares of Viatris Inc. - Common Stock are outstanding?
Viatris Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.